Exposure history impacts universal flu vax development, research says; Medigene touts early AML data;

> A new study suggests that immune system history could play a big role in scientists' ability to create a universal flu vaccine. Report

> Medigene unveiled "promising" early data from ongoing dendritic cell vaccine trials in patients with acute myeloid leukemia. Release

> The development of a new vaccine is one objective of a recently announced strategy to defeat tuberculosis as a public health threat by 2035. Report

> A University of Helsinki study demonstrated the potential for scientists to predict influenza evolution and create better seasonal vaccines by using genomic information from virus strains in circulation. Report

> Ann Arbor, MI-based NanoBio said its intranasal nanoemulsion adjuvanted chlamydia vaccine demonstrated efficacy in a mouse challenge. Release

And Finally... Science Friday examined the etymology of the word "vaccine." More

Suggested Articles

As COVID-19 vaccines advance, the FDA held an expert hearing Thursday to talk safety, efficacy, distribution plans and vaccine confidence—plus more. 

Moderna, racing ahead with COVID-19 vaccine R&D, completed enrollment for its late-stage trial—and moved one step closer to approval.

Since the FDA released new COVID-19 vaccine guidance, HHS Secretary Alex Azar has discussed firing FDA Commissioner Stephen Hahn, Politico reports.